Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VNJAVANJIA CORP

OTC · CIK 0001532383
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC1531 Operative Builders
FY end1231
XBRL facts103

Identity from submissions API

NameVANJIA CORP
CIK0001532383
TickersVNJA
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC1531 Operative Builders
EIN453051284
LEI—
Fiscal year end1231
State of incorporationTX TX
Phone713-898-6818
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • Vantone Realty Corp (2012-02-02T05:00:00.000Z → 2013-11-08T05:00:00.000Z)
Business address
4771 SWEETWATER BLVD #199
SUGAR LAND
TX
77479
TX
Mailing address
4771 SWEETWATER BLVD #199
SUGAR LAND
TX
77479
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

106 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q QUARTERLY REPORT 0001017386-26-000155 000-55508 261556998 34 1098583 1 1
2026-08-17 10-Q QUARTERLY REPORT 0001017386-26-000112 000-55508 261285569 34 1090017 1 1
2026-08-17 NT 10-Q NT 10-Q 0001017386-26-000109 000-55508 261285524 34 19088
2026-05-15 10-Q QUARTERLY REPORT 0001017386-26-000068 000-55508 26988125 34 1096479 1 1
2026-03-26 10-K ANNUAL REPORT 0001017386-26-000019 000-55508 26794151 34 1498228 1 1
2025-11-13 10-Q QUARTERLY REPORT 0001017386-25-000132 000-55508 251474836 34 1115950 1 1
2025-08-14 10-Q QUARTERLY REPORT 0001017386-25-000095 000-55508 251219840 34 1047809 1 1
2025-05-12 10-Q QUARTERLY REPORT 0001017386-25-000062 000-55508 25934002 34 1084780 1 1
2025-05-06 10-K/A 10 K/A 0001017386-25-000060 000-55508 25915538 34 1432265 1 1
2025-04-15 10-K ANNUAL REPORT 0001017386-25-000050 000-55508 25837867 34 1429263 1 1
2025-03-28 NT 10-K NT 10K 0001017386-25-000020 000-55508 25781160 34 19221
2024-11-12 10-Q QUARTERLY REPORT 0001017386-24-000255 000-55508 241442400 34 1167376 1 1
2024-09-26 8-K CURRENT REPORT 4.01,9.01 0001017386-24-000244 000-55508 241327627 34 192499 1 1
2024-08-27 UPLOAD filename1.pdf 0000000000-24-009742 000-55508 39717
2024-08-23 10-K/A 10-K/A 0001017386-24-000235 000-55508 241234840 34 32234
2024-08-19 UPLOAD filename1.pdf 0000000000-24-009458 000-55508 40890
2024-08-08 10-Q QUARTERLY REPORT 0001017386-24-000211 000-55508 241187002 34 1014051 1 1
2024-05-08 10-Q QUARTERLY REPORT 0001017386-24-000131 000-55508 24924950 34 1037783 1 1
2024-04-30 UPLOAD filename1.pdf 0000000000-24-004774 000-55508 44133
2024-03-27 10-K ANNUAL REPORT 0001017386-24-000046 000-55508 24786062 34 1376970 1 1
2023-11-08 10-Q QUARTERLY REPORT 0001017386-23-000345 000-55508 231386685 34 1034839 1 1
2023-08-14 10-Q QUARTERLY REPORT 0001017386-23-000301 000-55508 231168315 34 1021532 1 1
2023-05-10 10-Q QUARTERLY REPORT 0001017386-23-000182 000-55508 23904082 34 1037023 1 1
2023-02-27 10-K ANNUAL REPORT 0001017386-23-000078 000-55508 23675567 34 1325068 1 1
2022-11-08 10-Q QUARTERLY REPORT 0001017386-22-000488 000-55508 221367352 34 971737 1 1
2022-08-01 10-Q QUARTERLY REPORT 0001017386-22-000323 000-55508 221124917 34 979441 1 1
2022-05-12 10-Q QUARTERLY REPORT 0001017386-22-000232 000-55508 22916301 34 965653 1 1
2022-03-11 10-K ANNUAL REPORT 0001017386-22-000066 000-55508 22732410 34 1247445 1 1
2021-11-02 10-Q QUARTERLY REPORT 0001017386-21-000473 000-55508 211368727 34 870221 1 1
2021-08-10 10-Q vnja_10q-20210630.htm 0001017386-21-000313 000-55508 211159283 34 1082550 1 1
2021-05-04 10-Q QUARTERLY REPORT 0001017386-21-000138 000-55508 21887013 34 776237 1
2021-04-20 8-K 8k_vnja.htm 4.01 0001532383-21-000002 000-55508 21838061 34 13527
2021-03-25 10-K ANNUAL REPORT 0001017386-21-000067 000-55508 21769943 34 940953 1
2020-10-29 10-Q QUARTERLY REPORT 0001017386-20-000446 000-55508 201271474 34 691756 1
2020-07-31 10-Q QUARTERLY REPORT 0001017386-20-000239 000-55508 201063268 34 776687 1
2020-04-28 10-Q QUARTERLY REPORT 0001017386-20-000118 000-55508 20822698 34 790600 1
2020-03-19 10-K ANNUAL REPORT 0001017386-20-000068 000-55508 20727839 34 1039018 1
2019-11-12 10-Q QUARTERLY REPORT 0001017386-19-000296 000-55508 191207565 34 666098 1
2019-08-16 10-Q QUARTERLY REPORT 0001017386-19-000218 000-55508 191031162 34 794968 1
2019-08-15 NT 10-Q NT_10Q 0001532383-19-000006 000-55508 191029460 34 10864
2019-08-13 8-K CURRENT REPORT 4.01,9.01 0001017386-19-000210 000-55508 191017676 34 14524
2019-08-01 8-K/A 8ka_vnja_8_1_2019.htm 3.02 0001532383-19-000005 000-55508 19992162 34 13609
2019-06-06 8-K 8k_vnja.htm 3.02 0001532383-19-000003 000-55508 19882213 34 12762
2019-05-15 10-Q QUARTERLY REPORT 0001017386-19-000113 000-55508 19824958 34 830945 1
2019-04-02 8-K 8k_vnja_3_31_2019.htm 1.04,3.02 0001532383-19-000002 000-55508 19724004 34 12991
2019-04-02 10-K ANNUAL REPORT 0001017386-19-000079 000-55508 19722630 34 1044087 1
2019-03-29 NT 10-K nt_10K_vnja.htm 0001532383-19-000001 000-55508 19716035 34 11594
2018-12-31 8-K 8k_vj_12_31_2018.htm 3.02 0001532383-18-000010 000-55508 181259923 34 13887
2018-11-30 8-K 3.02 3.02 0001532383-18-000009 000-55508 181209557 34 13338
2018-11-13 10-Q vanjia_10q.htm 0001552781-18-000498 000-55508 181175178 34 624719 1
2018-10-26 D xslFormDX01/primary_doc.xml 06c 0001532383-18-000008 021-324461 181141068 33 6733
2018-08-09 10-Q/A vj10q6302018.htm 0001552781-18-000325 000-55508 181004500 34 662179 1
2018-08-07 10-Q vj10q6302018.htm 0001552781-18-000298 000-55508 18996832 34 159582
2018-07-02 8-K vj_6292018.htm 3.02 0001532383-18-000007 000-55508 18931259 34 13695
2018-06-28 8-K vj_6282018.htm 2.01,3.02 0001532383-18-000006 000-55508 18922913 34 14523
2018-06-18 8-K vj_6182018.htm 3.02 0001532383-18-000005 000-55508 18903439 34 12384
2018-05-07 10-Q vj_10q.htm 0001552781-18-000199 000-55508 18809932 34 601212 1
2018-03-28 10-K vj_10k.htm 0001552781-18-000126 000-55508 18718140 34 711265 1
2017-11-01 10-Q vj_10q.htm 0001552781-17-000597 000-55508 171167310 34 511901 1
2017-08-11 10-Q/A a10q6302017vanjia.htm 0001552781-17-000486 000-55508 171023347 34 618591 1
2017-08-10 10-Q a10q6302017vanjia.htm 0001552781-17-000480 000-55508 171021235 34 171675
2017-08-01 8-K OTHER EVENTS 5.02,8.01 0001532383-17-000007 000-55508 17996055 34 1600353
2017-05-03 10-Q vj-10q.htm 0001552781-17-000279 000-55508 17806457 34 591714 1
2017-03-27 10-K vanjia_10k.htm 0001552781-17-000162 000-55508 17714509 34 814437 1
2016-11-10 10-Q vanjia_10q.htm 0001552781-16-002081 000-55508 161985905 34 578335 1
2016-08-05 10-Q vj-10q6302016.htm 0001552781-16-001882 000-55508 161809233 34 583070 1
2016-05-10 10-Q vj_10q3312016.htm 0001552781-16-001629 000-55508 161634502 34 583339 1
2016-03-29 10-K vj12312015.htm 0001552781-16-001449 000-55508 161533567 34 871407 1
2015-11-13 10-Q vj10q9302015.htm 0001552781-15-001000 000-55508 151226935 34 612836 1
2015-09-10 8-A12G 8-A_Vanjia.htm 0001532383-15-000002 000-55508 151100557 34 16805
2015-07-16 10-Q vj10q6302015.htm 0001552781-15-000694 333-179302 15991760 34 572296 1
2015-05-13 10-Q vj.htm 0001552781-15-000561 333-179302 15857220 34 736165 1
2015-03-27 10-K vj10k12312015.htm 0001552781-15-000346 333-179302 15730457 34 1106232 1
2014-11-04 10-Q vj10q9302014.htm 0001552781-14-000937 333-179302 141191117 34 691186 1
2014-08-08 10-Q vj10q6302014.htm 0001552781-14-000692 333-179302 141025751 34 719667 1
2014-05-09 10-Q vj10q3312014.htm 0001552781-14-000394 333-179302 14829926 34 579007 1
2014-03-28 10-K vt10k12312013.htm 0001552781-14-000214 333-179302 14722749 34 853002 1
2013-11-08 8-K AMENDMENT TO ARTICLE OF INCORPORATION 5.03 0001532383-13-000001 333-179302 131203461 34 19545
2013-10-29 10-Q vt10q9302013.htm 0001552781-13-000033 333-179302 131174795 34 553898 1
2013-08-09 10-Q vt_10q6302013.htm 0001524829-13-000031 333-179302 131024649 34 771449 1
2013-05-14 10-Q vantone_10q.htm 0001554757-13-000300 333-179302 13839339 34 546772 1
2013-03-28 10-K deepi_10k.htm 0001554757-13-000166 333-179302 13722827 34 727619 1
2012-10-31 10-Q vantonerealty_financial-10q.htm 0001554757-12-000291 333-179302 121170443 34 557549 1
2012-08-13 10-Q/A vantone_10q.htm 0001554757-12-000067 333-179302 121026406 34 551005 1
2012-08-10 10-Q vantone_10q.htm 0001554757-12-000065 333-179302 121024902 34 550994 1
2012-05-15 10-Q vantone_10q.htm 0001533621-12-000174 333-179302 12841162 34 518419 1
2012-05-15 424B3 PROSPECTUS 0001532383-12-000018 333-179302 12841102 33 320748
2012-05-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2012-05-14 16:00:00 9999999995-12-001545 333-179302 12840807 33 1656
2012-05-14 S-1/A S-1 REGISTRATION 0001532383-12-000016 333-179302 12837794 33 337704
2012-05-14 CORRESP filename1.htm 0001532383-12-000015 8251
2012-05-14 S-1/A S-1 REGISTRATION 0001532383-12-000013 333-179302 12835908 33 366223
2012-05-11 CORRESP filename1.htm 0001532383-12-000012 4512
2012-05-11 CORRESP filename1.htm 0001532383-12-000011 8160
2012-05-11 UPLOAD filename1.pdf 0000000000-12-024677 54559
2012-05-09 S-1/A S-1 REGISTRATION STATEMENT 0001532383-12-000010 333-179302 12823931 33 359147
2012-05-07 UPLOAD filename1.pdf 0000000000-12-023633 54827
2012-04-24 S-1/A S-1 REGISTRATION STATEMENT 0001532383-12-000009 333-179302 12775191 33 340071
2012-04-23 CORRESP filename1.htm 0001532383-12-000008 3982
2012-04-23 CORRESP filename1.htm 0001532383-12-000007 7205
2012-04-05 S-1/A S-1 REGISTRATION STATEMENT 0001532383-12-000006 333-179302 12746303 33 485281
2012-03-19 S-1/A S-1 REGISTRATION STATEMENT 0001532383-12-000005 333-179302 12699910 33 393335
2012-03-19 UPLOAD filename1.pdf 0000000000-12-013811 49235
2012-03-12 S-1/A REDLINE COPY 0001532383-12-000004 333-179302 12682243 33 367002
2012-03-05 S-1/A S-1 REGISTRATION STATEMENT 0001532383-12-000003 333-179302 12667410 33 5059474
2012-02-28 UPLOAD filename1.pdf 0000000000-12-010437 62437
2012-02-02 S-1 S-1 REGISTRATION 0001532383-12-000002 333-179302 12564825 33 458354

Latest XBRL company facts

One latest value per concept from companyfacts (103 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
dei EntityPublicFloat Entity Public Float USD 60,000 2020-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 4,720 2026-06-30 2026 Q2 10-Q 2026-08-17 0001017386-26-000112
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 50,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001017386-24-000255
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 3,866 2011-12-31 2012 FY 10-K 2013-03-28 0001554757-13-000166
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 194,399 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 742,001 2024-01-01 2024-12-31 2024 FY 10-K/A 2025-05-06 0001017386-25-000060
us-gaap Assets Assets USD 55,215 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap AssetsCurrent Assets, Current USD 63,359 2026-03-31 2026 Q1 10-Q 2026-05-15 0001017386-26-000068
us-gaap Cash Cash USD 27,759 2020-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 58,639 2026-03-31 2026 Q1 10-Q 2026-05-15 0001017386-26-000068
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -42,330 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 55,215 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -7,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 55,215 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 100 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001552781-18-000325
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 10.00B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 48,000 2018-12-31 2019 FY 10-K 2020-03-19 0001017386-20-000068
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 600 2012-06-30 2012 Q2 10-Q/A 2012-08-13 0001554757-12-000067
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 2,058 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap DebtInstrumentUnusedBorrowingCapacityAmount Debt Instrument, Unused Borrowing Capacity, Amount USD 100,000 2016-12-31 2017 Q2 10-Q 2017-08-11 0001552781-17-000486
us-gaap DebtIssuanceCostsLineOfCreditArrangementsNet Debt Issuance Costs, Line of Credit Arrangements, Net USD 5,200 2016-12-31 2017 Q2 10-Q 2017-08-11 0001552781-17-000486
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 20,349 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 11,412 2023-12-31 2023 FY 10-K 2024-03-27 0001017386-24-000046
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 10,439 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 130,090 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD -20,349 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 10,439 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 31,378 2015-03-31 2015 Q1 10-Q 2015-05-13 0001552781-15-000561
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 8,800 2017-12-31 2018 FY 10-K 2019-04-02 0001017386-19-000079
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 5,200 2017-06-30 2017 Q2 10-Q 2017-08-11 0001552781-17-000486
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001552781-18-000498
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.34 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 4,376 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 37,500 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-19 0001017386-20-000068
us-gaap GainLossOnSaleOfPropertiesBeforeApplicableIncomeTaxes Gain (Loss) on Sale of Properties, before Applicable Income Taxes (Deprecated 2020-01-31) USD -12,025 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001552781-18-000498
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 37,500 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -11,412 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001017386-23-000078
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -7,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 11,412 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-27 0001017386-23-000078
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001017386-22-000066
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -4,376 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-27 0001552781-15-000346
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 4,720 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-17 0001017386-26-000112
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 8,100 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001017386-20-000068
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -3,866 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001554757-13-000166
us-gaap IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits USD 18,985 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001017386-24-000255
us-gaap InventoryRealEstate Inventory, Real Estate USD 25,000 2012-12-31 2013 Q1 10-Q 2013-05-14 0001554757-13-000300
us-gaap InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation Investment Company, Distributable Earnings (Loss), Accumulated Appreciation (Depreciation) USD -68,713 2017-12-31 2017 FY 10-K 2018-03-28 0001552781-18-000126
us-gaap InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss) USD 182,277 2021-06-30 2021 Q2 10-Q 2021-08-10 0001017386-21-000313
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 10,000 2011-08-19 2012-12-31 2012 FY 10-K 2013-03-28 0001554757-13-000166
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 55,215 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap LiabilitiesCurrent Liabilities, Current USD 8,800 2017-12-31 2018 FY 10-K 2019-04-02 0001017386-19-000079
us-gaap LineOfCredit Long-term Line of Credit USD 100,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001552781-18-000498
us-gaap LineOfCreditFacilityAverageOutstandingAmount Line of Credit Facility, Average Outstanding Amount USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001552781-18-000498
us-gaap LineOfCreditFacilityFairValueOfAmountOutstanding Line of Credit Facility, Fair Value of Amount Outstanding USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0 2016-12-31 2017 Q2 10-Q 2017-08-11 0001552781-17-000486
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap LoansAndLeasesReceivableAllowance Loans and Leases Receivable, Allowance USD 42,330 2020-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 48,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -7,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap NetInvestmentIncome Net Investment Income USD -3,866 2011-08-19 2012-12-31 2012 FY 10-K 2013-03-28 0001554757-13-000166
us-gaap NetInvestmentIncomeInsuranceEntity Net Investment Income, Insurance Entity (Deprecated 2013-01-31) USD -5,589 2011-08-19 2012-12-31 2012 FY 10-K 2013-03-28 0001554757-13-000166
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3,950 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001017386-26-000068
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 75,810 2025-09-30 2025 Q3 10-Q 2025-11-13 0001017386-25-000132
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 139,184 2025-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap OtherIncome Other Income USD 1,400 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-07 0001552781-18-000199
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 8.89B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001017386-26-000019
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 48,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -6,100 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001017386-25-000132
us-gaap RealEstateInsurance Real Estate Insurance USD 25,000 2011-08-19 2014-09-30 2014 Q3 10-Q 2014-11-04 0001552781-14-000937
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 8,800 2017-12-31 2018 Q3 10-Q 2018-11-13 0001552781-18-000498
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -142,184 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap Revenues Revenues USD 50,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001017386-25-000132
us-gaap SECScheduleIIIRealEstateInvestmentPropertyNet SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Investment Property, Net USD 25,000 2014-09-30 2014 Q3 10-Q 2014-11-04 0001552781-14-000937
us-gaap SharesIssued Shares, Issued shares 67,169 2013-12-31 2013 FY 10-K 2014-03-28 0001552781-14-000214
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 55,215 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD -50,000 2012-06-30 2012 Q2 10-Q/A 2012-08-13 0001554757-12-000067
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 742,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001017386-21-000067
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 20,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001017386-20-000068
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 16,900 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001017386-20-000068
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 25,000 2011-08-19 2011-12-31 2015 FY 10-K 2016-03-29 0001552781-16-001449
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -2,058 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-27 0001552781-17-000162
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 30.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001017386-22-000066
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 30.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001017386-26-000155

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →